Search Results 291-300 of 16262 for monoclonal antibody

  1. Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

  2. Chronic Myelogenous Leukemia Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as pembrolizumab, may interfere with the ... Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody ...

  3. Publications - Jennifer B. Cowart, M.D. - Mayo Clinic

    ... Monoclonal Antibody Screening Score. Mayo Clin Proc Innov Qual Outcomes. 2023 Apr; 7 (2):109-121 Epub 2023 Jan 11. View PubMed; Cortes MP, Schultz CS, Isha S ...

  4. Clinical trials - Oncology (Medical)

    Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such ...

  5. Health Topics - Mayo Clinic News Network

    Monoclonal antibody treatment helps couple recover quickly from COVID-19. Dan Lea. February 23, 2021. COVID-19. Changes for visitors at Mayo Clinic in Rochester.

  6. Bullous Pemphigoid Clinical Trials

    Ixekizumab is a recombinant high-affinity fully human monoclonal antibody that targets IL-17A Immunoglobulin gamma-1 (IgG1)/kappa-class. The purpose of this ...

  7. Infliximab-dyyb (intravenous route, subcutaneous route) - Mayo Clinic

    This medicine is a monoclonal antibody that works on the immune system. This medicine is available only with your doctor's prescription. This product is ...

  8. Skin Cancer Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as ipilimumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor ...

  9. Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as alemtuzumab, can bind to and kill malignant lymphocytes. PURPOSE: This phase I/II trial is studying the side effects and best ...

  10. Non-Small Cell Lung Cancer Clinical Trials

    Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...